Healthcare -
Biotechnology - NASDAQ - US
$ 1.61
-1.72 %
$ 8.83 M
Market Cap
-0.07
P/E
BTAI - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities BTAI - BioXcel Therapeutics, Inc.
36.7 M
LAST VALUE
-38.28%
2 YEAR CAGR
15.27%
5 YEAR CAGR
0.00%
10 YEAR CAGR